BRCA Genetic Testing
BRCA Genetic Testing in Dehradun
BRCA genetic testing is a specialized medical test used to detect mutations in the BRCA1 and BRCA2 genes, which are associated with an increased risk of certain cancers. These genes normally help repair damaged DNA, but mutations in these genes may significantly increase the risk of breast cancer, ovarian cancer, fallopian tube cancer, and other cancers.
BRCA testing helps identify individuals who may have a hereditary cancer risk, allowing doctors to recommend preventive strategies, early screening, or personalized treatment options.
Why is BRCA Testing Important?
BRCA genetic testing plays a crucial role in cancer prevention and risk assessment. It helps identify individuals who may have an inherited risk of developing certain cancers.
Identifying Inherited Cancer Risk
BRCA testing helps determine whether a person carries inherited gene mutations linked to cancer.
Early Detection and Prevention
Testing allows doctors to recommend preventive measures and early screening strategies.
Personalized Cancer Treatment
Results help doctors create personalized treatment plans tailored to genetic risk.
Family Risk Assessment
Testing provides valuable information for family members about their potential cancer risk.
Improved Monitoring and Screening
Individuals with BRCA mutations can benefit from more frequent monitoring and screening.
Benefits of Robotic Surgery
Robotic surgery is an advanced minimally invasive technique that offers several advantages compared to traditional open surgery by providing enhanced precision and control.
Because of these advantages, robotic surgery is increasingly preferred for many complex gynecologic procedures requiring high precision.
How is BRCA Testing Performed?
BRCA testing is a simple and safe procedure used to identify mutations in the BRCA1 and BRCA2 genes that may increase the risk of certain cancers.
Genetic Counseling
Patients first receive genetic counseling to understand the purpose of BRCA testing and its possible outcomes.
Sample Collection
A blood sample or saliva sample is collected for genetic analysis.
Laboratory Analysis
The collected sample is analyzed in a laboratory to check for mutations in the BRCA1 and BRCA2 genes.
Result Interpretation
Specialists interpret the results to determine whether a BRCA gene mutation is present.
Preventive Planning
The results help doctors recommend appropriate monitoring, prevention, or treatment strategies if needed.
Risk Management After BRCA Testing
If a BRCA mutation is detected, doctors may recommend several preventive strategies to reduce the risk of developing cancer and to ensure early detection.
A personalized risk-management plan helps patients take proactive steps to reduce cancer risk and maintain long-term health.
Why Choose Genetic Cancer Screening?
Genetic cancer screening helps identify inherited cancer risks early and enables doctors to create effective prevention and treatment strategies.
Genetic screening empowers patients and families to take proactive steps toward cancer prevention and better long-term health.
BRCA Genetic Testing – Frequently Asked Questions
Find answers to common questions about BRCA genetic testing, a screening method used to detect inherited mutations that may increase the risk of breast and ovarian cancer.
BRCA genetic testing is a medical test used to identify mutations in the BRCA1 and BRCA2 genes. These mutations can significantly increase the risk of developing breast and ovarian cancers.
BRCA testing may be recommended for individuals with a strong family history of breast or ovarian cancer, early-onset cancer, or known BRCA mutations in the family.
BRCA testing is usually performed using a blood or saliva sample. The sample is analyzed in a laboratory to detect mutations in the BRCA1 and BRCA2 genes.
If a BRCA mutation is detected, doctors may recommend increased cancer screening, preventive medications, lifestyle changes, or risk-reducing surgery depending on the patient’s risk profile.
BRCA genetic testing and counseling are available under the guidance of Dr. Yamini Kansal, an AIIMS-trained Gynaecological Oncologist specializing in hereditary cancer risk assessment and advanced cancer care.